Health Press Release – Monthly Newsletter March 2011
Tuesday, March 1, 2011
Verona Pharma Applies for Approval to Test RPL554 in UK Clinical Trials
LONDON, January 31, 2011 – Verona Pharma plc (AIM:VRP.L) the biotechnology company dedicated to
discovering new drugs for the treatment of chronic respiratory diseases, has
applied to the Medicines and Healthcare Products Regulatory Agency (MHRA),
the Governmental agency in the UK with responsibility for standards of
safety, quality and performance of new drug treatments, to conduct clinical
trials in …. Source article on Gaea Times at : Verona Pharma Applies for Approval to Test RPL554 in UK Clinical Trials.
Hold Your Own ‘Thinner Party’ to Save Pennies and Lose Pounds This January
New Look alli Website Full of Healthy Recipes to Cook You and Your Friends Slim
LONDON, January 31, 2011 – January is traditionally the month we all tighten our belts, whether that
means cutting down on the nights out to save a few pennies, or swapping mince
pies for muesli to lose a few pounds – or …. Original article : Hold Your Own 'Thinner Party' to Save Pennies and Lose Pounds This January.
Hoya Announces Third Quarter Financial Results
TOKYO, January 31, 2011 – HOYA Corporation today announced financial results for the third quarter
ended December 31, 2010. Net sales were up 1.5% to 108,449 million yen
year-on-year, and operating income rose 4.7% to 19,897 million yen. Net
income was up 12.0% to 13,210 million yen, and earnings per share were 30.62
yen compared with 27.24 yen …. Original source : Hoya Announces Third Quarter Financial Results.
Bill Gates Releases Third Annual Letter, Calling for Sustained Foreign Aid to Boost Global Health and Development
Speaking at Historic Roosevelt House, Gates Outlines Why the World Should Prioritize Vaccines and the Eradication of Polio
NEW YORK, January 31, 2011 – Bill Gates, co-chair of the Bill & Melinda Gates Foundation, argues the
case for polio eradication and expanded childhood immunization in his third
annual letter released today. The letter, a personal account of … Original article on : Bill Gates Releases Third Annual Letter, Calling for Sustained Foreign Aid to Boost Global Health and Development.
Abbott’s TREK(R) Coronary Balloon System Now Available in the United States and Japan
With Previous CE Mark in Europe, the TREK Balloon Dilatation Catheter System is Now Available in All Major Markets Worldwide
ABBOTT PARK, Illinois, January 31, 2011 – Abbott (NYSE: ABT) today announced it has received regulatory clearance
in the United States and approval in Japan for its TREK(R) and MINI-TREK(TM)
Coronary Dilatation Catheters for the treatment of … Read more >>.
Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator
GREENWICH, Connecticut, January 31, 2011 – Mederi Therapeutics Inc. announced today that it has received FDA 510(k)
clearance for its new MDRF1 Generator.
The Mederi RF Generator powers the Stretta(R) System for treatment of
Gastroesophageal Reflux Disease (GERD) as well as the Secca(R) System for
Bowel Incontinence or Bowel Control Disorder (BCD).
…. Source article on Gaea Times at : Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator.
The Global Pharmaceutical Market is Expected to Mature to $220 Billion by 2016, in Spite of the Inclement Effects of the Healthcare Reform Bill
Biopharmaceutical Market Worldwide is Set for High Growth.
DALLAS, February 1, 2011 – The US biopharmaceutical market which has previously contributed 60% of
world market share will witness a sudden growth spurt, triggered by a spate
of policy changes, grants and the recent Health Care Reform Bill and AARC.
However, as the rest of …. Original source : The Global Pharmaceutical Market is Expected to Mature to $220 Billion by 2016, in Spite of the Inclement Effects of the Healthcare Reform Bill.
Simbionix Launches MentorLearn: Providing the Optimal Solution for Training Program Management
CLEVELAND, February 1, 2011 – Simbionix USA Corporation, the world's leading provider of medical
education and simulation technology, released its new MentorLearn system at
the International Meeting on Simulation in Healthcare (IMSH) last week.
Simbionix's exciting new MentorLearn platform now provides the optimal
solution for managing all training and education needs for the Simbionix …. Original source : Simbionix Launches MentorLearn: Providing the Optimal Solution for Training Program Management.
Aircraft Medical Wins Long-running Video Laryngoscope Patent Litigation Against Verathon
Judge Finds Aircraft's McGrath(R) Series 5 Does not Infringe Verathon's "Glidescope" Patent
EDINBURGH, Scotland, February 1, 2011 – Aircraft Medical Ltd ("Aircraft") is pleased to announce that
judgment has been passed in its favour in the long running patent
infringement litigation between it and US rival Verathon Medical Inc.
("Verathon"), a subsidiary of Roper Industries Inc.
… Read more : Aircraft Medical Wins Long-running Video Laryngoscope Patent Litigation Against Verathon.
Optimax Refractive Conference: The Year’s Ultimate Vision Event
Celebrating 20 Years of Laser Eye Surgery
LONDON, February 2, 2011 – Since the early stages of laser eye surgery (
www.optimax.co.uk/treatments_explained.aspx), Optimax have been
bringing the latest procedures to the UK public, and can now look back
proudly at the thousands of lives which have been transformed by their
treatments.
This week, the laser eye … Read the original article on Gaea Times at : Optimax Refractive Conference: The Year's Ultimate Vision Event.
The 2011 Reaxys(R) PhD Prize for Chemistry Research Opens for Entries
NEUCHATEL, Switzerland, February 2, 2011 – Elsevier Properties SA announces the launch of the 2011 Reaxys PhD Prize,
a global competition for candidates currently studying for a PhD or having
completed a PhD within the last 12 months.
The prize will be awarded for original and innovative research in
organic, organometallic and inorganic chemistry … Read more >>.
Elsevier Acquires Oncology Journal Portfolio From Cancer Information Group
Journals Provide the Highest Quality Content Focused on Tumor-Specific Topics That Affect Oncologists and Their Patients
NEW YORK, February 2, 2011 – Elsevier (www.elsevier.com), the leading global
publisher of scientific, technical, and medical information products and
services, announced today that it acquired the oncology portfolio of journals
previously published by CIG Media Group LP., (operated as Cancer Information
Group). …. Source article : Elsevier Acquires Oncology Journal Portfolio From Cancer Information Group.
Bupa’s ‘How are you Britain?’ Report Reveals Rise of Athletic Older People
LONDON, February 2, 2011 – Bupa has revealed that the over-60s are fitter than ever, leaving their
younger counterparts behind when it comes to exercise.
Research from the Bupa 'How are you Britain?' report reveals that UK
residents who are 60 plus are three times more likely to exercise every day
than those in …. Source article on Gaea Times at : Bupa's 'How are you Britain?' Report Reveals Rise of Athletic Older People.
VWR International, LLC Acquires AMRESCO Inc.
Acquisition Provides VWR Life Science Customers Even Greater Choice and Value
RADNOR, Pennsylvania, February 2, 2011 – VWR International, LLC, a global leader in distributing laboratory
supplies and services, announced today that it has acquired AMRESCO Inc., a
manufacturer and supplier of high quality biochemicals and reagents for
Molecular Biology, Life Sciences, Proteomics, Clinical and Histology areas of
research …. Source article on Gaea Times at : VWR International, LLC Acquires AMRESCO Inc..
Pharmaceutical Industry Bracing for Record Patent Expiries, EvaluatePharma Data Reveals
LONDON, February 2, 2011 – Thirteen US blockbusters will lose patent protection over the
next two years, data from EvaluatePharma show, highlighting the challenges
facing the pharmaceutical industry in the coming years. With the reporting
season in full swing it is no wonder that several big pharmaceutical company
chief executives have warned of tough times ahead.
Trimega Laboratories Showcased to Promote Manchester’s Life Science Industry to European Investors
LONDON, February 2, 2011 – Trimega Laboratories, the leading hair alcohol and drug testing company,
is to be one of a few Manchester businesses in the life science sector to
promote their success on the European stage to encourage further investment
in the city.
On Wednesday 2 February, Trimega will host 10 journalists from … Original article on : Trimega Laboratories Showcased to Promote Manchester's Life Science Industry to European Investors.
Digna Biotech and CIMA Receive EUR 1.3 Million Funding for Acute Intermittent Porphyria Gene Therapy as Part of an EU FP7 Grant for Clinical Development of Orphan Drugs
MADRID, February 3, 2011 – Digna Biotech and the Centro de Investigaci??n M??dica Aplicada (CIMA) de
la Universidad de Navarra announced today that the European Union (EU) has
finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and
CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million
respectively for the clinical …. Original article on Gaea Times at : Digna Biotech and CIMA Receive EUR 1.3 Million Funding for Acute Intermittent Porphyria Gene Therapy as Part of an EU FP7 Grant for Clinical Development of Orphan Drugs.
Cepheid and FIND Announce Collaboration to Develop HIV Viral Load Test
Partnership Expected to Expand Molecular Test Offering in Developing Country Markets
SUNNYVALE, California and GENEVA, February 3, 2011 – Cepheid (Nasdaq: CPHD) and FIND (Foundation for Innovative New
Diagnostics) today announced a new collaboration to accelerate the
development of a rapid molecular test for the measurement of human
immunodeficiency virus (HIV) viral load.
The Xpert(R) …. Source article on Gaea Times at : Cepheid and FIND Announce Collaboration to Develop HIV Viral Load Test.
Spinning for the Upper Body From Virgin Active Health Clubs
Health Club Chain Launches Kranking(R), the Brand New Upper Body Workout From Spinning Creator Jonny G
LONDON, February 3, 2011 – Virgin Active Health Clubs (www.virginactive.co.uk/) is
launching the latest US exercise trend, Kranking(R), into all 71 of its
health clubs nationwide following successful trials in West London and
Sheffield. Innovated by spinning guru, Jonny G, Kranking(R) aims … Read more »»».
The Sixth International Symposium on Molecular Insect Science to Feature Leading Researchers in the Field
Conference to be Held 2-5 October 2011, in the Netherlands
OXFORD, England, February 7, 2011 – Elsevier, the leading publisher of scientific, technical and medical
information products and services, announces that the Sixth International
Symposium on Molecular Insect Science is the first of the series to be held
outside the US. This year the conference will take place … Read the original article on Gaea Times at : The Sixth International Symposium on Molecular Insect Science to Feature Leading Researchers in the Field.
alli(R) Launching a New Chewable Tablet in 2011
LONDON, February 7, 2011 – GlaxoSmithKline (GSK) today announces that it has received a licence
extension for alli, the first pharmacy-only weight loss aid licensed for use
throughout Europe. This license extension is for new chewable tablets. The
new alli tablets are planned to be on sale in pharmacies throughout the UK in
April this year.
…. Read the original article : here.
Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the AAD in New Orleans
LONDON, NEW YORK and HAMILTON, Bermuda, February 7, 2011 – — Transfersome(R) Trans-Dermal Delivery System potentiates terbinafine's
anti-fungal activity in TDT 067 –
Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma"), the global private
equity firm focused on the biotechnology and pharmaceutical industries,
announced today the presentation of key in-vitro data at the American Academy
of Dermatology …. Read the original article : Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the AAD in New Orleans.
Astellas Enters into Partnership With Optimer on Life-Saving Antibiotic Fidaxomicin
Product Already Filed With European Medicines Agency
STAINES, England, February 7, 2011 – Astellas Pharma Europe Ltd. announced today that it has entered into an
exclusive collaboration and license agreement with Optimer Pharmaceuticals
Inc., San Diego for the development and commercialisation of fidaxomicin, an
investigational antibiotic for Clostridium difficile infection (CDI) in
Europe and certain other countries in the … Read the original article on Gaea Times at : Astellas Enters into Partnership With Optimer on Life-Saving Antibiotic Fidaxomicin.
LighterLife and the National Obesity Forum Launch The UK Obesity Barometer
HARLOW, England, February 7, 2011 – LighterLife and the National Obesity Forum have launched The UK Obesity
Barometer to track weight gain in the UK.
The UK Obesity Barometer shows that around 1.2 million people in the UK
moved into the 'overweight' or 'obese' category over the festive season*
pushing levels to a new … Read more : LighterLife and the National Obesity Forum Launch The UK Obesity Barometer.
Health Robotics Re-Enters the Italian Market With its World-Leading Robotics and Software Automation Tools
BOZEN, Sud-Tirol, Italy, February 7, 2011 – Health Robotics today announced that it recently decided to re-start
sales and service operations in Italy, after a three-year absence in
connection with a prior agreement with Gruppo Loccioni. With over 60 hospital
customers under contract carried forward from the company's 2006-2007
presence in the Italian market, Health Robotics is on …. Original source : Health Robotics Re-Enters the Italian Market With its World-Leading Robotics and Software Automation Tools.
Almac Opens Analytical Labs in New US Headquarters
SOUDERTON, Pennsylvania, February 7, 2011 – Almac's new 240,000 sq. ft. North American Headquarters, built on 40
acres in Souderton, PA, north of Philadelphia is part of the Almac Group's
integrated services solutions strategy. The new facility delivers
full-service, integrated clinical packaging, drug supply management and
technology solutions to pharmaceutical and biotech clients.
The facility [..] Read the original article: here.
ConvaTec Announces New Appointments to Leadership Team
Changes Align with Company's Commitment to Growth
SKILLMAN, New Jersey, February 7, 2011 – ConvaTec, a world-leading developer and marketer of innovative medical
technologies for community and hospital care, today announced the appointment
of several executives to new positions within the company.
Nino Pionati has been appointed President, Intercontinental in a newly
aligned region that … Read more >>>.
Fairfax Cryobank Announces Fairfax FaceMatch(TM) for Sperm Donors: Similar to System Used by the FBI, Computer Program Compares Photos to Find Resemblance
Fairfax Cryobank announces a new and exciting computer program to help patients "match" a photo of their partner or some other individual to find their perfect sperm donor
FAIRFAX, Virginia, February 7, 2011 – "Patients choosing donor sperm often wonder if they can find a donor who
resembles their partner or someone else. Fairfax Cryobank's new … Original article on : Fairfax Cryobank Announces Fairfax FaceMatch(TM) for Sperm Donors: Similar to System Used by the FBI, Computer Program Compares Photos to Find Resemblance.
PharmaMar Commences Clinical Trial in U.S. with New Antitumor Product, PM060184
PM060184 is a new marine-derived compound which has shown strong antitumor activity in preclinical models and a favorable safety profile in animal toxicology studies
MADRID, February 8, 2011 – PharmaMar SA (Grupo Zeltia, ZEL.MC) has announced the commencement of a
Phase I clinical trial with PM060184 for patients with solid tumors. PM060184
is a marine-derived synthetically-produced compound … Read more »».
NHS to Tackle Hospital Superbugs With Groundbreaking Irisys Infrared Technology
Solution Aims to Save Lives – and GBP1 Billion Every Year
LEAMINGTON SPA, England, February 8, 2011 – NHS figures show that about nine per cent of patients actually acquire
infections during a hospital stay. This costs the Health Service around
GBP1billion annually – money that could be saved by something as simple as
regular hand washing.
/C O R R E C T I O N – Virgin Active/
LONDON, February 8, 2011 – In the news release, "Spinning for the Upper Body From Virgin Active Health
Clubs" issued on 3 Feb 2011 14:12 GMT, by Virgin Active over PR Newswire, we
are advised by a representative of the company that In the news release
"Spinning for the Upper Body from Virgin Active Health Clubs", … Original article on : /C O R R E C T I O N — Virgin Active/.
One-Year European Registry Data Released for Popliteal Stenting With SUPERA(R)
Zero Fractures and Impressive Patency Results Reported for Unique Stent from IDEV Technologies
LEIPZIG, Germany, February 8, 2011 – Data from the Leipzig Registry tracking the results of patients treated
with the SUPERA(R) stent for peripheral arterial disease (PAD) of the
popliteal artery were reported during the recent 2011 Leipzig Interventional
Course (LINC). The SUPERA stent is CE … Original source on Gaea Times at : One-Year European Registry Data Released for Popliteal Stenting With SUPERA(R).
CID at JIM 2011
CID to Update Interventional Cardiologists on Cre8(TM) Drug Eluting Stent at the 2011 Joint Interventional Meeting
ROME, February 8, 2011 – CID spa, a European company leader in interventional medicine, will
present the key technologies implemented on CID's Cre8(TM) DES as well as all
the new preclinical data at the Joint Interventional Meeting (JIM) during the
Lunch Symposium …. Read the original article : CID at JIM 2011.
Core Children’s Services Launch New Website
BROMSGROVE, England, February 8, 2011 – Core Children's Services is pleased to announce the launch of its new
website to promote the broad range of services available for children, young
people and families across the UK.
In the midst of the changing climate within children and family services,
the new website addresses the ever-increasing … Read : Core Children's Services Launch New Website.
ALQAEM International to Make Noninvasive Glucose Monitor Available in the Region
DUBAI, United Arab Emirates, February 10, 2011 – The Health Care Division of ALQAEM International FZE, the
exclusive master distributor for the M.E.N.A. region of the UFIT(R)
noninvasive medical device created by Biosign Technologies Inc. of Canada, is
pleased to announce that it has placed orders for delivery this quarter and
will begin a limited release in March …. Source : ALQAEM International to Make Noninvasive Glucose Monitor Available in the Region.
Oncos Therapeutics Increases Clinical Momentum With Appointment of Chief Medical Officer
HELSINKI, February 9, 2011 – Oncos Therapeutics, a biotech company developing novel cancer
therapeutics based on its next generation oncolytic viruses, announced today
the appointment of Dr. Mikael von Euler, MD, PhD, FFPM, as Chief Medical
Officer. Earlier this year, the Company announced the appointments of Dr.
Jonathan Knowles and Dr. Robert Burns to its Board of Directors.
…. Source article : Oncos Therapeutics Increases Clinical Momentum With Appointment of Chief Medical Officer.
MarketsandMarkets: Global Injectable Drug Delivery Market To Be Worth $29,981 Million By 2015
DALLAS, February 9, 2011 – According to a new market research report, 'Global Injectable Drug
Delivery Market (2010 – 2015)', published by MarketsandMarkets
(www.marketsandmarkets.com), the global injectable drug delivery
market shows a significant growth potential and is expected to rise from
$14,994 million in 2009 to $29,981 million in 2015 at a CAGR of 12.3% during
2010-2015.
…. Original article : MarketsandMarkets: Global Injectable Drug Delivery Market To Be Worth $29,981 Million By 2015.
Frost & Sullivan Technology Innovation Award Conferred on AQTIS Medical BV for its Pioneering Ellanse(TM)
LONDON, February 9, 2011 – The 2011 Frost & Sullivan European Technology Innovation of the Year
Award in Dermal Fillers is presented to AQTIS Medical BV in recognition of
its pioneering Ellanse(TM).
(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
"This novel range of dermal fillers supports safe and cost-effective
treatments in aesthetic medicine and surgery, through … Read more >>.
Stop Proofreading – Start Bunnying! Schlafender Hase Releases New Version of the Text Verification Tool (TVT)
FRANKFURT, Germany, February 9, 2011 – Schlafender Hase ("sleeping hare") GmbH is not just changing the way the
pharmaceutical industry does proofreading. It is changing the word for
proofreading. "Have you 'bunnied' your text? That's the way one of our top US
customers asks if the proofreading process has been done," said Willie
Schnaubelt, managing director of Schlafender [..] Read the original article: here.
Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial
MOUNTAIN VIEW, California, February 9, 2011 – Concentric Medical, Inc. today announced that the first patients were
enrolled in TREVO 2 (Thrombectomy REvascularization of large Vessel
Occlusions) at Oregon Health & Science University in Portland, Oregon and at
Capital Health in Trenton, New Jersey. Oregon Health & Science enrolled the
first patient in TREVO 2 and Capital Health …. Original article on Gaea Times at : Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial.
ReportsnReports – The European Minimally Invasive Spinal Implant Markets Are Expected Exceed EUR90 Million By 2017
DALLAS, February 9, 2011 – ReportsnReports announces it will carry European Markets for Minimally
Invasive Spinal Devices 2011 Research Report in its store.
Browse the complete Report on:
www.reportsnreports.com/reports/59358-european-markets-for-minimally-i
nvasive-spinal-devices-2011.html
Search More Then 60000 Market Research Reports at
www.reportsnreports.com/
The European minimally invasive spinal implant markets are expected
exceed EUR90 …. Original source : ReportsnReports – The European Minimally Invasive Spinal Implant Markets Are Expected Exceed EUR90 Million By 2017.
Syngenta CEO Interviewed on New Strategy and 2010 Results
LONDON, February 9, 2011 – Syngenta, the world's largest agribusiness, says the decision to
integrate its Crop Protection and Seeds business would take the operations to
a "higher level of performance".
Earlier today in an interview with financial news website
www.cantos.com, Syngenta CEO Mike Mack said the first stages of the
integration would be complete …. Source : Syngenta CEO Interviewed on New Strategy and 2010 Results.
Torchmark Corporation Reports Fourth Quarter and Year-End 2010 Results
MCKINNEY, Texas, February 9, 2011 – Torchmark Corporation (NYSE: TMK) reported today that for the quarter
ended December 31, 2010, net income was $1.91 per share, compared with $1.36
per share for the year-ago quarter. Net operating income for the quarter was
$1.68 per share, compared with $1.47 per share for the year-ago quarter.
… Read : Torchmark Corporation Reports Fourth Quarter and Year-End 2010 Results.
Zebinix, Novel Once-Daily Anti-Epileptic Treatment, Launches in Spain
HATFIELD, England, February 10, 2011 – Zebinix(R) (eslicarbazepine acetate), an add-on (adjunctive) therapy for
adults with partial-onset seizures, with or without secondary generalisation
(where the seizure spreads to both sides of the brain), has been launched
today in Spain by Eisai and BIAL in a co-promotion.
In 2009, the European Commission approved Zebinix based …. Source : Gaea News Network.
Mobily Launches Mobile Baby(TM) Service for Transmitting Sonograms to Subscribers’ Mobile Phones
Mobily is the first mobile operator worldwide enabling parents to receive and send ultrasound scans wirelessly to their friends, family and loved ones
SAN DIEGO and RIYADH, Saudi Arabia, February 10, 2011 – Saudi Arabian telecommunications company Mobily and Great Connection
Inc., creator of the innovative Mobile Baby(TM) service, announced the launch
of the first mobile medical …. Original article : Mobily Launches Mobile Baby(TM) Service for Transmitting Sonograms to Subscribers' Mobile Phones.
MarketsandMarkets: Global Anesthesia and Respiratory Devices Market Worth US$12.7 Billion by 2015
DALLAS, February 10, 2011 – According to a new market research report, "Global Anesthesia and
Respiratory Devices Market (2010-2015)" published by MarketsandMarkets
(www.marketsandmarkets.com), the total global anesthesia and
respiratory devices market is expected to be worth US$12.7 billion by 2015,
out of which GE Healthcare will account for nearly 12% of the total revenues.
The global market is expected … Read more »»».
Pevion Appoints Didier Hoch, Former President of Sanofi Pasteur MSD, as Chairman of the Board
ITTIGEN, Switzerland and BERN, Switzerland, February 10, 2011 – Pevion Biotech Ltd. today announced the appointment of Didier
Hoch as Chairman of its Board of Directors. Until recently, Dr Hoch was
President of Sanofi-Pasteur MSD, where he played a pivotal role in launching
innovative vaccines, such as Gardasil(R), in Europe.
Prior to his position … Read more »».
Medivir Announces Start of Phase 1a Trial of the Hepatitis C Polymerase Inhibitor TMC649128
HUDDINGE, Sweden, February 10, 2011 – Medivir AB (OMX: MVIR), the emerging research-based specialty
pharmaceutical company focused on infectious diseases, today announces the
start of a phase 1a clinical trial with TMC649128 intended for the treatment
of chronic hepatitis C virus infection.
TMC649128 is a nucleoside NS5B polymerase inhibitor that has already
demonstrated an attractive …. Read the original article : Medivir Announces Start of Phase 1a Trial of the Hepatitis C Polymerase Inhibitor TMC649128.
Second Annual Latin America ‘Green Exchange Conference’ Hosted by Informex Focuses on a Sustainable Future for Chemistry
PRINCETON, New Jersey, February 10, 2011 – Informex (www.informex.com), the leading meeting place for buyers
and sellers of high-value chemistry for a broad range of applications, today
announced details of its second Latin American Green Exchange Conference,
which returns in 2011 to Sao Paulo, Brazil. The event will be held in
September 2011, with further details to be …. Source : Gaea News Network.
Novasep and instrAction Expand Alliance to Include Taxane Purification
Companies Will Develop Solutions to Change Manufacturing Paradigm for New and Generic Anti-cancer Compounds
POMPEY, France and LUDWIGSHAFEN, Germany, February 10, 2011 – Novasep, a leading supplier of manufacturing solutions to the
life science industries, and instrAction, a manufacturer of innovative
chromatographic stationary phases for API purification processes, today
announce they have expanded their worldwide strategic alliance to …. Read the original article : here.
Medivir Signs Research & Development Collaboration on Dengue Virus
HUDDINGE, Sweden, February 14, 2011 – Highlights of the Collaboration:
– Collaboration with Janssen Pharmaceutica N.V. Focused on Dengue Virus
– Both Parties to Contribute 50:50 Resources to the Research Program
– Strengthens Medivir's Presence in Infectious Diseases And Utilises
… Read more >>>.
Orascom Telecom, Mobinil and Great Connection Collaborate to Launch Mobile Baby(TM) Service in Egypt
Mobilizing DICOM sonar images for remote diagnostics of pregnant women in Egypt is now possible with Mobile Baby(TM)
BARCELONA, Spain, February 15, 2011 – Orascom Telecom and Mobinil, in collaboration with Great Connection,
today announced the launch of a pilot project to bring mobile DICOM sonar
images remote diagnostics to pregnant women in Egypt.
…. Source article : Orascom Telecom, Mobinil and Great Connection Collaborate to Launch Mobile Baby(TM) Service in Egypt.
Doro Reveals Global Strategic Partnerships: MyGlucoHealth + Medixine
Easy-to-use Mobiles now Connect Seamlessly With Leading Diabetes Management Solution and Provide One-Touch Medication Reminder Service
LUND, Sweden, February 15, 2011 – Doro is revealing the first strategic elements of its global mHealth
initiative. The company's mobiles will now be used for the delivery of care
assistance services and solutions.
Jerome Arnaud, President and …. Original article : Doro Reveals Global Strategic Partnerships: MyGlucoHealth + Medixine.
QPS Expands Into Toxicology Services With Acquisition of the Preclinical Unit of DCB Taiwan
NEWARK, Delaware and TAIPEI, Taiwan, February 14, 2011 – QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract
research organization providing testing services to support preclinical and
clinical research and development, announced the acquisition of the Center of
Toxicology and Preclinical Sciences (CTPS) from Taiwan's Development Center
for Biotechnology (DCB). CTPS, located in Taipei, will become a division of
QPS-Taiwan.
…. Source : QPS Expands Into Toxicology Services With Acquisition of the Preclinical Unit of DCB Taiwan.
Home-Based Billers Now Join Med DataCare Pro’s Healthcare Network
DALLAS, February 14, 2011 – Med DataCare Pro, a healthcare service provider based in
Dallas since 1999, now joins hands with home-based billers to create a
network of healthcare professionals at a national level for the mutual
benefit of home-based billers, physicians and Med DataCare Pro.
According to the CEO and Managing Partner of … Read more >>>.
Graham Nicholls of Almac Group to Speak on Adaptive Trial Designs and Clinical Supplies at CTS Europe Conference
SOUDERTON, Pennsylvania, February 14, 2011 – The Almac Group announced today that Graham Nicholls, Director of
Biostatistics for Almac's Clinical Technologies business unit, will be
speaking at the Clinical Trial Supply Europe conference (CTS Europe) held in
Barcelona, Spain, 22-23 February 2011. The conference will be attended by two
of Almac's business units directly involved with providing an …. Source article : Graham Nicholls of Almac Group to Speak on Adaptive Trial Designs and Clinical Supplies at CTS Europe Conference.
European Operating Room Nurses Demand Unified Training; Greater Recognition at EU Level
February 15th: European Day of Perioperative Nursing
BRUSSELS and DUBLIN, February 14, 2011 – On the occasion of the 6th European Day of Perioperative
Nursing, to be celebrated on 15 February 2011, the European Operating Room
Nurses Association (EORNA) calls for the urgent implementation, at EU level,
of a minimum basic level of perioperative nursing education, a credit-based
continuous … Read more »»».
Elsevier / MEDai Enhances Real-Time Clinical Surveillance System for Hospitals
Pinpoint Review(R) Enhancements Allow Hospitals and Clinicians to Provide Safer, More Efficient and Less Costly Care
ORLANDO, Florida, February 14, 2011 – Elsevier / MEDai, a leading provider of advanced clinical analytic
healthcare solutions, announced today the launch of the latest version of
Pinpoint Review(R), its real-time, clinical surveillance system for
hospitals. The new version will feature an …. Original source : Elsevier / MEDai Enhances Real-Time Clinical Surveillance System for Hospitals.
Ziehm Imaging Receives Frost & Sullivan Award
Mobile C-arms Recognized as Integral Part of Interventional Radiology in Hybrid ORs
NUREMBURG, Germany, February 14, 2011 – Ziehm Imaging has received Frost & Sullivan's European Product Leadership
Award 2011 in the interventional radiology category. The Ziehm Vision RFD
mobile C-arm ranked strongly in all assessment categories and led the field
in terms of functionality, innovation, market acceptance, … Read : Ziehm Imaging Receives Frost & Sullivan Award.
The Lightning Process Tops UK’s Largest Ever ME/CFS Survey
LONDON, February 14, 2011 – In the ME Association's survey of people with ME/CFS, the Lightning
Process (LP) has emerged as the best of 25 commonly used approaches for
helping people feel 'greatly improved'.
The "Managing my ME" survey – the largest ever survey of patient and
carer evidence on issues relating to management …. Source article : The Lightning Process Tops UK's Largest Ever ME/CFS Survey.
Smile Train and Operation Smile Boards Agree to Merge
NEW YORK, February 14, 2011 – The boards of directors of Smile Train and Operation Smile, two of the
leading cleft lip and cleft palate charities in the world, today announced
that they have voted to combine the two organizations into a single new
entity, to be known as Operation Smile Train.
In a …. Source : Smile Train and Operation Smile Boards Agree to Merge.
Torchmark Corporation to Present at Bank of America Merrill Lynch Insurance Conference
MCKINNEY, Texas, February 14, 2011 – Torchmark Corporation (NYSE: TMK) announced today that its Chief
Executive Officer, Mark McAndrew, and Chief Financial Officer, Gary Coleman,
will present Wednesday, February 16, 2011 at the Bank of America Merrill
Lynch Insurance Conference in New York City. Torchmark's presentation is
scheduled to begin at 3:10 p.m. EST.
…. Source : Gaea News Network.
Amsterdam Molecular Therapeutics Reports Full Year Results 2010
AMSTERDAM, February 16, 2011 – Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field
of human gene therapy, today reported its results for the year to December
31, 2010.
Key Highlights
– Glybera(R) Marketing Authorisation Application remains on track with
European Medicines Agency (EMA);
…. Source : Gaea News Network.
Nfocus Neuromedical, Inc. Luna(TM) Aneurysm Embolization System Receives CE Mark
Significant milestone for innovative device designed to treat brain aneurysms -
PALO ALTO, California, February 15, 2011 – Nfocus Neuromedical, Inc., an innovative medical device company with a
focus on the next generation treatment for brain aneurysms, announced today
that its Luna(TM) Aneurysm Embolization System (AES) received CE Mark for the
treatment of patients with brain aneurysms. The … Original article on : Nfocus Neuromedical, Inc. Luna(TM) Aneurysm Embolization System Receives CE Mark.
M&S Pet Insurance Reveals 42% of Brits Would Choose Dog or Car Over Partner
LONDON, February 15, 2011 – M&S Pet Insurance has revealed that if it came down to "it's me or the
pet", 42% of people would always choose their cat or dog over their partner,
according to a recent survey it conducted.
The survey found that almost 42% of cat and dog owners would …. Source : Gaea News Network.
The World Heart Federation, sanofi-aventis and Boehringer Ingelheim Announce Collaboration on Worldwide AF Awareness Campaign
GENEVA, February 15, 2011 – The World Heart Federation, sanofi-aventis and Boehringer
Ingelheim have announced their collaboration on the AF AWARE (Atrial
Fibrillation AWareness And Risk Education) campaign today, to raise awareness
of atrial fibrillation (AF) and its links to severe consequences including
cardiovascular (CV) mortality, stroke and CV hospitalizations. The campaign
aims to promote education around the risks …. Source : The World Heart Federation, sanofi-aventis and Boehringer Ingelheim Announce Collaboration on Worldwide AF Awareness Campaign.
The Food ingredients Portfolio Explores New Territories
AMSTERDAM, February 15, 2011 – In 2011, the Food ingredients portfolio continues its geographical
expansion and develops further with the industry it serves. Economic
recovery, investment in emerging markets and focus on health characterise the
industry this year. Consequently, the Fi portfolio has taken upon new
challenges launching new shows in the Philippines and China, and investing
further in …. Read the original article : The Food ingredients Portfolio Explores New Territories.
Lloydspharmacy is Recognised for its Excellent Customer Service
COVENTRY, England, February 15, 2011 – Lloydspharmacy, the pharmacy retailer, has been recognised for its
excellence in customer services following a recent nationwide customer
satisfaction survey.
The Institute of Customer Service (ICS) awarded Lloydspharmacy second
place in the Retail (non-food) sector behind John Lewis in the bi-annual UK
Customer Satisfaction Index which is compiled from … Original article on : Lloydspharmacy is Recognised for its Excellent Customer Service.
Macmillan Cancer Support Announces Charity Football Match
LONDON, February 15, 2011 – Macmillan Cancer Support has announced that a host of popular Emmerdale
and Coronation Street stars are heading for the football pitch on Saturday
19th February for an all-star match which aims to raise over GBP20,000 for
the UK's leading cancer care charity. Kicking off at 1pm at Manchester
Regional Arena, the match will …. Read the original article : here.
Leading Expert in Health Claims to Speak at Hi Online Conference
AMSTERDAM, February 15, 2011 – One of the world's leading experts on health claims, Patrick Coppens from
Europe Advisory Services (EAS), will be speaking at the Hi online event and
conference. He will be joining a panel discussion, at 1pm, CET, to give his
perspective on whether EFSA is a positive force for change in the food
industry. …. Source article : Leading Expert in Health Claims to Speak at Hi Online Conference.
Lloydspharmacy Appoints Tony Page as Managing Director
COVENTRY, England, February 15, 2011 – Lloydspharmacy has announced the appointment of Tony Page as managing
director of the 1,650 strong community pharmacy chain.
Tony joins the organisation following a 23 year career in the retail
sector, most recently in the role of commercial director for Lenta Ltd where
he helped to lead the …. Original source : Lloydspharmacy Appoints Tony Page as Managing Director.
Brainlab Launches Refreshed Website
New Website Offers Intuitive Dynamic Content
MUNICH, February 15, 2011 – Brainlab, a leader in software-driven systems for targeted, less-invasive
medical treatments, invites customers, physicians and patients to a refreshed
online experience at brainlab.com (www.brainlab.com). The re-invented
site offers an intuitive user experience, dynamic videos and enhanced content
and design.
"At Brainlab, we make medical technology …. Read the original article : Brainlab Launches Refreshed Website.
Texas Instruments and ANT+ Showcase First Commercially Available Smartphone with Native Connectivity to ANT+ Health/Fitness Devices at Mobile World Congress
BARCELONA, Spain, February 15, 2011 – ANT Wireless ("ANT" www.thisisant.com), a division of Dynastream
Innovations Inc., and Texas Instruments Incorporated (TI) (NYSE: TXN) today
showcase the Sony Ericsson Xperia(TM) arc, the first commercially available
smartphone to natively communicate with the ultra-low power (ULP) ANT+
network of health and fitness devices. Featured as part of TI's exhibition at
Mobile World …. Source article : Texas Instruments and ANT+ Showcase First Commercially Available Smartphone with Native Connectivity to ANT+ Health/Fitness Devices at Mobile World Congress.
/C O R R E C T I O N – Amsterdam Molecular Therapeutics B.V/
AMSTERDAM, February 16, 2011 – In the news release, "Amsterdam Molecular Therapeutics Reports Full Year
Results 2010" issued on 16 Feb 2011 06:00 GMT, by Amsterdam Molecular
Therapeutics B.V AEX:AMT over PR Newswire, we are advised by a
representative of the company that the full year figures should have
been included in the dissemination.
Complete, corrected release follows
…. Source article on Gaea Times at : /C O R R E C T I O N — Amsterdam Molecular Therapeutics B.V/.
MarketsandMarkets: Global Weight Loss & Diet Management Products & Services Market (2010 – 2015)
DALLAS, February 16, 2011 – The "Global Weight Loss & Diet Management Products & Services Market
(2010 – 2015)" analyzes weight management market with respect to market
drivers, opportunities, and trends in the diverse geographical regions
including North America, Europe, Asia, and others.
Browse market data tables and in-depth TOC on Global Weight Loss … Read more : MarketsandMarkets: Global Weight Loss & Diet Management Products & Services Market (2010 – 2015).
‘At Least 68 Million Votes’ for The King’s Speech
MEMPHIS, Tennessee, February 16, 2011 – Jane Fraser, president, The Stuttering Foundation
(www.stutteringhelp.org), issued the following reaction to the
Upcoming Oscar awards:
"One in 20 children stutter at some point; one in 100 go on to a lifetime
of stuttering. Sixty-eight million people around the world stutter. If you
ask the stuttering community what movie … Original article on : 'At Least 68 Million Votes' for The King's Speech.
Study: Casual Video Games Demonstrate Significant Ability to Reduce Depression and Anxiety; Clinical Importance Highlighted
First-of-Its-Kind Clinical Study by East Carolina University Establishes Efficacy of Bejeweled(R) and Other Games in Reducing Clinical Depression and Anxiety
DUBLIN, February 16, 2011 – East Carolina University's Psychophysiology Lab and Biofeedback
Clinic today revealed the results of a year-long randomized, controlled
clinical study that measured the efficacy of so-called "casual"
video games (CVGs) in reducing symptoms of … Original article on : Study: Casual Video Games Demonstrate Significant Ability to Reduce Depression and Anxiety; Clinical Importance Highlighted.
Avesthagen Introduces First-in-Class Vegetarian DHA Omega 3 Essential Fatty Acid, Scouts for Global Licensing Partnerships, Manufacturing Facilities
BANGALORE, India, February 16, 2011 – Avesthagen Limited announced completion of a landmark project
for the development of AvestaDHA(TM) – a vegetarian source of DHA
(docohexanoic acid) omega 3 essential fatty acid based on an innovative
approach using naturally occurring microalgae.
DHA is a polyunsaturated mega-3 fatty acid found throughout
the body. More specifically, DHA …. Original source : Avesthagen Introduces First-in-Class Vegetarian DHA Omega 3 Essential Fatty Acid, Scouts for Global Licensing Partnerships, Manufacturing Facilities.
Statutory Regulation Best to Safeguard the Public
LONDON, February 16, 2011 – The Association of Traditional Chinese Medicine (UK), ATCM,
welcomes today's Health Department announcement on statutory regulation of
herbal medicine and traditional Chinese medicine practitioners by the Health
Professions Council.
Since the House of Lords Select Committee report on
Complementary and Alternative Medicine in 2000 suggesting a statutory
regulation for herbal medicine … Read more : Statutory Regulation Best to Safeguard the Public.
Japan Science and Technology Agency (JST) to Automate Indexing of 90 Journals in SciVerse Scopus
AMSTERDAM, February 16, 2011 – Elsevier and the Japan Science and
Technology Agency (JST) have reached a new agreement for the automated
delivery of the metadata of 90 J-STAGE journals in SciVerse Scopus,
reflecting the mutual commitment of Elsevier and JST to the global
dissemination of scientific research.
"SciVerse Scopus continues to improve indexing peer-reviewed …. Source : Japan Science and Technology Agency (JST) to Automate Indexing of 90 Journals in SciVerse Scopus.
Elsevier Launches Sustainable Computing: Informatics and Systems
New Journal to Publish Research Finding Related to Energy-Aware and Thermal-Aware Management of Computing Resources
AMSTERDAM, February 16, 2011 – Elsevier, a leading global publisher of scientific, technical,
and medical information products and services, announced today the launch of
Sustainable Computing: Informatics and Systems (
www.elsevier.com/locate/suscom). The journal aims to publish the
myriad of research findings related to energy-aware …. Read the original article : Elsevier Launches Sustainable Computing: Informatics and Systems.
Canadian ‘Bowel Cancer International’ Member Celebrates Cancer Awareness With its International Public Service Announcement Contest
TORONTO, February 16, 2011 – The Colorectal Cancer Association of Canada (CCAC) invites aspiring
advertising creators and filmmakers to use their talents to raise global
colorectal cancer awareness by participating in the Second Annual
International Public Service Announcement (PSA) Contest.
In addition to cash prizes of up to $4,500 CAD, the contest offers the
opportunity …. Source article on Gaea Times at : Canadian 'Bowel Cancer International' Member Celebrates Cancer Awareness With its International Public Service Announcement Contest.
European eHealth Week 2011 Confirms Participation of Prominent Organizations, Partners, Exhibitors and Country Pavilions
EU-wide Networking and Information Platform Unites Fragmented Industry Behind a Common Goal: Advancing the Application of eHealth in Europe
BRUSSELS and BUDAPEST, Hungary, February 17, 2011 – eHealth Week 2011 (ehealthweek.org/) announced today that some of
the world's most prestigious and influential eHealth organisations and
industry partners will participate in this year's event to exchange views
with EU …. Original source : European eHealth Week 2011 Confirms Participation of Prominent Organizations, Partners, Exhibitors and Country Pavilions.
Almac Announce Launch of Bioinformatics Consultancy
Almac Your Bioinformatics Partner
CRAIGAVON, Northern Ireland, February 17, 2011 – Almac's Diagnostics business unit today announced the launch of its
Bioinformatics Consultancy service.
Almac's Bioinformatics Consultancy supports discovery and development of
biomarkers as well as enabling an in-depth understanding of biology by
partnering with customers in the pharmaceutical, biotech and diagnostics
setting, from the initial …. Original article on Gaea Times at : Almac Announce Launch of Bioinformatics Consultancy.
Health is High on the Agenda as President Banda Opens National Nutrition Forum
LUSAKA, Zambia, February 17, 2011 – Today His Excellency, Mr. Rupiah Banda, President of the
Republic of Zambia, officially opened the National Nutrition Consultative
Forum at a ceremony in Livingstone in the Southern Province.
The meeting focused on national food security and highlighted
President Banda's commitment to providing a better future for all Zambians,
not …. Original article : Health is High on the Agenda as President Banda Opens National Nutrition Forum.
Elsevier is Improving Quality, Efficiency of Healthcare With “Smart Content” for Next-Generation Clinical Decision Support
Enriching and Providing Unprecedented Levels of Access to Content Can Drive Smarter Healthcare Applications, Improve Data Delivery, Increase Efficiency and Enhance Patient Care Quality
PHILADELPHIA, February 17, 2011 – To improve healthcare quality while reducing costs, Elsevier
(www.elsevier.com/), a global leader in medical and health
information, will unveil the next generation of clinical decision support
(CDS) featuring Smart … Original source on Gaea Times at : Elsevier is Improving Quality, Efficiency of Healthcare With "Smart Content" for Next-Generation Clinical Decision Support.
Intrinsic Enrolls First Patient in Barricaid(R) Trial
WOBURN, Massachusetts, February 17, 2011 – Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus
closure devices, announced today that it has enrolled the first patient,
December 17, 2010, in a Randomized Clinical Trial of its Barricaid(R) device.
Barricaid is designed to prevent reherniations following lumbar discectomy,
while allowing the surgeon to retain as much of the …. Source : Intrinsic Enrolls First Patient in Barricaid(R) Trial.
Medivir – The Phase 3 Program for TMC435 in Treatment-Naive Patients and Patients who Have Relapsed After Prior Interferon-Based Treatment has Now Started
HUDDINGE, Sweden, February 18, 2011 – Medivir AB (OMX: MVIR), the emerging research-based specialty
pharmaceutical company focused on infectious diseases, notes that its
development partner, Tibotec Pharmaceuticals, announced today that the global
phase 3 studies with TMC435 in treatment-naive patients and patients who have
relapsed after prior SOC treatment have started.
Phase 3 Program in …. Source : Gaea News Network.
Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus
HUDDINGE, Sweden, February 22, 2011 – Medivir AB (OMX: MVIR), the emerging research-based specialty
pharmaceutical company focused on infectious diseases, announces today
further positive results from the phase 2b PILLAR (C205) study of TMC435 in
treatment-naive patients with hepatitis C virus (HCV) genotype-1.
– TMC435 was safe and well tolerated with no clinically
…. Source article on Gaea Times at : Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus.
Objet to Showcase 3D Printing Solutions for Digital Dentistry at LMT Lab Day, Chicago
Objet Digital Dentistry Solutions Offer Reduced Model Fabrication Times and Increased Output Per Technician
BILLERICA, Massachusetts, February 22, 2011 – Objet Geometries Ltd. (www.objet.com/), the innovation leader in
3D printing for rapid prototyping and additive manufacturing, will be
showcasing its advanced 3D printing solutions (
www.objet.com/INDUSTRIES/Dental/) for digital dentistry at LMT Lab Day
East, February 25-26, in Chicago, the … Read the original article on Gaea Times at : Objet to Showcase 3D Printing Solutions for Digital Dentistry at LMT Lab Day, Chicago.
Datong, Provider of Drug Decision Support Products in China, is Acquired by Elsevier
Datong Offers Drug Decision Support Software Developed for Chinese Hospitals to Improve Drug Usage Safety and Reduce Prescription Errors
SHANGHAI, February 21, 2011 – Elsevier (www.elsevier.com), the leading global publisher of
scientific, technical, and medical information products and services,
announced today the acquisition of Shanghai Datong Medical Information
Technology Co., Ltd. (www.da-tong.net), a leading drug decision
support provider in …. Source : Gaea News Network.
Elsevier and the Arabidopsis Information Resource (TAIR) Connect Research Articles to Genetic and Molecular Biology Data
AMSTERDAM, February 21, 2011 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, and TAIR – The Arabidopsis Information
Resource (www.arabidopsis.org/), announce their next step in
interconnecting the diverse elements of scientific research. All articles on
Elsevier's electronic platform SciVerse ScienceDirect (
www.sciverse.com/) that describe Arabidopsis genes and use AGI codes
(e.g. AT4G32520) will now … Read more »»».
Canadian Cardiovascular Society and Elsevier Publish Issue of the Canadian Journal of Cardiology
Issue Marks the Beginning of Their Partnership, Includes CCS Atrial Fibrillation Guidelines
PHILADELPHIA, Pennsylvania, February 21, 2011 – Elsevier and the Canadian Cardiovascular Society (CJC) announce the
publication of the January/February 2011 issue of the Canadian Journal of
Cardiology (CJC), the first in their partnership. This theme issue focused on
atrial fibrillation includes the long-awaited Canadian Cardiovascular Society
Atrial …. Source : Canadian Cardiovascular Society and Elsevier Publish Issue of the Canadian Journal of Cardiology.
ReportsnReports – Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
DALLAS, February 21, 2011 – ReportsnReports announces it will carry the Blood: The Worldwide Market
for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood
Products Research Report in its store.
Browse the complete Report on:
www.reportsnreports.com/reports/57615-blood-the-worldwide-market-for-
blood-products-blood-testing-bl.html
(Due to the length of this URL, it may be necessary to copy and … Read the original article on Gaea Times at : ReportsnReports – Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products.
Nordion Signs Share Purchase Agreement to Divest MDS Nordion S.A.
Best Medical Belgium Inc. to Purchase Nordion's Belgian Operations
OTTAWA, Canada, February 21, 2011 – Nordion Inc. (TSX: NDN; NYSE: NDZ), a leading provider of products and
services to the global health science market, today announced it has signed a
share purchase agreement (SPA) with Best Medical Belgium (Best Medical) for
the divestiture of the Company's Belgian operations, …. Source article : Nordion Signs Share Purchase Agreement to Divest MDS Nordion S.A..
Advancell Announces Positive Phase I/IIa Results With Acadra (Acadesine) in Chronic Lymphocytic Leukemia – CLL
BARCELONA, Spain, February 21, 2011 – ADVANCELL (www.advancell.net/), an emerging
biopharmaceutical company, today announced positive results from a clinical
study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia
(www.cancer.gov/) (CLL) patients resistant to current therapies. The
company also announced promising non-clinical results in Multiple Myeloma
(MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders.
Synergism of Acadra in combination with …. Read the original article : here.
Sanofi Pasteur and International Vaccine Institute Partner Against Dengue
LYON, France, February 21, 2011 – Sanofi Pasteur, the vaccines division of sanofi-aventis Group
(EURONEXT: SAN and NYSE: SNY), announced today that it is partnering with the
International Vaccine Institute (IVI) to support the recently launched Dengue
Vaccine Initiative (DVI). Sanofi Pasteur and the IVI will aim to raise
awareness and to work to move dengue vaccination higher …. Original article on Gaea Times at : Sanofi Pasteur and International Vaccine Institute Partner Against Dengue.
LighterLife Announces New Healthy Ready Meals
HARLOW, England, February 21, 2011 – LighterLife has launched new healthy ready meal options to help over 50%
of the UK* who are currently overweight or obese.
The new launch comes at the same time as new figures are released
indicating that the NHS could become bankrupt in 10 years as a result … Original source on Gaea Times at : LighterLife Announces New Healthy Ready Meals.
Elsevier / MEDai and dbMotion Partner to Deliver Powerful Health Analytics Solutions to Payers and Providers
New Alliance Leverages Semantically Harmonized Health Data to Optimize Business and Clinical Intelligence Derived From Predictive Modeling and Analytics
ORLANDO, Florida, February 21, 2011 – Elsevier / MEDai (www.medai.com/), a leading health information
company with award-winning solutions for the improvement of care delivery,
and dbMotion (www.dbmotion.com/), an innovative provider of connected
healthcare solutions, today announced they have formed … Read this article on Gaea Times at : Elsevier / MEDai and dbMotion Partner to Deliver Powerful Health Analytics Solutions to Payers and Providers.
Sanofi Pasteur Supports Polio Eradication at First International Stock Exchange Event
Sanofi Pasteur Stands Shoulder to Shoulder With Rotary International During NYSE and EURONEXT Bell-ringing Ceremonies
LYON, France and SWIFTWATER, Pennsylvania, February 23, 2011 – Sanofi Pasteur, the vaccines division of sanofi-aventis Group
(EURONEXT: SAN and NYSE: SNY), today will participate in the first
international bell-ringing event by a company listed on NYSE Euronext. The
events will acknowledge past …. Source : Gaea News Network.
Autonomy Taps Into the Power of the Healthcare Community With Auminence World
New Capabilities Enable Healthcare Professionals to Connect and Collaborate in Real-Time, Improving Quality of Care at Lower Costs
ORLANDO, Florida, February 22, 2011 – HIMSS11 — Autonomy Corporation plc (LSE: AU. or AU.L), a global leader
in infrastructure for the enterprise, today unveiled a new expertise location
module and intelligence connectors for Autonomy Auminence, the company's
powerful point-of-care …. Source : Gaea News Network.
Abbott Launches a CE Marked KIF6 Test in Europe
A New Innovative Marker for Coronary Heart Disease
WIESBADEN, Germany, February 22, 2011 – Abbott (NYSE: ABT) announced today the availability of the CE-marked KIF6
diagnostic test for use on the m2000 instrument system. The KIF6 genotyping
assay, detects a genetic marker that may be used in conjunction with clinical
evaluation and patient assessment for the identification of … Read more »»».
Dan David Prize 10th Anniversary 2011 Laureates Announced: The Coen Brothers – for Cinema; Marcus Feldman – for Evolution; Cynthia Kenyon and Gary Ruvkun – for Ageing
President of the Republic of Italy, Giorgio Napolitano, to Receive 2010 Prize
TEL AVIV, Israel, February 22, 2011 – The international Dan David Prize, which annually awards three prizes of
US$1 million each for outstanding achievement, announced the names of its
2011 laureates today.
(Photo:
www.newscom.com/cgi-bin/prnh/20110222/438685 )
The Dan David Prize, … Read : Dan David Prize 10th Anniversary 2011 Laureates Announced: The Coen Brothers – for Cinema; Marcus Feldman – for Evolution; Cynthia Kenyon and Gary Ruvkun – for Ageing.
Maximising Efficiency in Clinical Outsourcing
MUNICH, Germany, February 22, 2011 – Driving clinical development and speeding time to market through
effective relationship management will be two of the key themes discussed at
Pharma IQ's 2nd Annual Global Clinical Outsourcing Forum this May.
A recent survey carried out by Pharma IQ revealed some telling stats
about the current market activities; … Read more : Maximising Efficiency in Clinical Outsourcing.
Ingenuity Systems and Covance Collaborate to Support Next-Generation Sequencing Research
REDWOOD CITY, California, February 23, 2011 – Ingenuity(R) Systems, a leading provider of information and analytics
solutions for life science researchers, today announced a research
collaboration with Covance Genomics Laboratory (www.covance.com/cgl) for
next-generation sequencing (NGS) data analysis. Covance Genomics Laboratory,
a leading provider of genomics solutions for the drug discovery and
development industry, and Ingenuity will work together to …. Source : Gaea News Network.
New Initiative in the Fight Against Neglected Tropical Diseases
LEIDEN, Netherlands, February 23, 2011 – Today, a new initiative, based in the Netherlands, is being launched in
the fight against neglected tropical diseases: The European Solutions
Enterprise for Neglected Diseases (euSEND). euSEND is a joint initiative of
the Academic Medical Center of the University of Amsterdam (AMC), the Royal
Tropical Institute (KIT), the Amsterdam Institute for Global … Read this article on Gaea Times at : New Initiative in the Fight Against Neglected Tropical Diseases.
New NICE Guidelines – All Children and Young People With Suspected Food Allergy Should be Offered an Allergy Test
UPPSALA, Sweden, February 23, 2011 – The first guidelines for food allergy in children and young people issued
by NICE, National Institute for health and Clinical Excellence, recommend
routine use of allergy tests in NHS primary care and community settings to
confirm suspected food allergy. These new evidence-based guidelines support
earlier diagnosis and assessment of food allergy and … Original source on Gaea Times at : New NICE Guidelines – All Children and Young People With Suspected Food Allergy Should be Offered an Allergy Test.
Oncolytics Biotech(R) Inc. Announces Completion of Enrollment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients With Metastatic Colorectal Cancer
CALGARY, Alberta, February 23, 2011 – Oncolytics Biotech Inc. ("Oncolytics") (TSX: ONC) (NASDAQ: ONCY)
announced today that enrollment has been completed in a U.K. translational
clinical trial investigating intravenous administration of REOLYSIN in
patients with metastatic colorectal cancer prior to surgical resection of
liver metastases (REO 013). The principal investigator is Professor Alan
Melcher of St. James's University Hospital …. Original article : Oncolytics Biotech(R) Inc. Announces Completion of Enrollment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients With Metastatic Colorectal Cancer.
Leaders in Pre Formulation and Formulation to Meet This April
LONDON, February 23, 2011 – Senior leaders from across the industry will meet at Pharma
IQ's Global Pre Formulation and Formulation Summit in Amsterdam this April to
discuss latest developments and challenges in the field.
With the cost of discovering and developing a new drug
predicted to tip at approximately $900 million, the pressure … Read the original article on Gaea Times at : Leaders in Pre Formulation and Formulation to Meet This April.
Agendia Receives Fifth FDA Clearance for Industry Leading MammaPrint(R) Assay
IRVINE, California and AMSTERDAM, February 23, 2011 – Agendia, a world leader in molecular cancer diagnostics, today
announced that the company has received its fifth U.S. Food and Drug
Administration (FDA) clearance for MammaPrint(R), its widely used breast
cancer recurrence assay. The new clearance is comprised of two additional
Agilent Microarray scanners and two Agilent Bioanalyzers, expanding
laboratory capacity … Original article on : Agendia Receives Fifth FDA Clearance for Industry Leading MammaPrint(R) Assay.
Colorcon Expands Nutraficient Product Portfolio to Include High Productivity, PVA-Based Formulations for Food Supplement Coating
HARLEYSVILLE, Pennsylvania, February 23, 2011 – Colorcon, Inc., today announced the expansion of its Nutraficient(R),
food supplement coating product line to include PVA-based, high-productivity
systems designed specifically for use on food supplements marketed within the
EU.
European Commission Directive (2010/69/EU), already adopted in the UK,
allows the use of existing additives in certain food supplement …. Original article : Colorcon Expands Nutraficient Product Portfolio to Include High Productivity, PVA-Based Formulations for Food Supplement Coating.
Berkshire Equine Vet Struck Off for Dishonesty and Breaching Racing Rules
LONDON, February 23, 2011 – The Disciplinary Committee of the Royal College of Veterinary Surgeons
last night [22 February 2011] directed that a veterinary surgeon from
Berkshire be removed from the Register, following his administration of a
prohibited substance to a racehorse and his subsequent attempts to conceal
his actions.
At a six-day hearing that …. Source : Berkshire Equine Vet Struck Off for Dishonesty and Breaching Racing Rules.
OrthoAccel Technologies, Inc. Announces New Scientific Advisor
HOUSTON, February 23, 2011 – OrthoAccel Technologies, Inc. (www.acceledent.co.uk) developers of
the AcceleDent System (www.acceledent.co.uk), a medical device to
accelerate orthodontic treatment, announced this week that it has engaged Dr.
Dawei Liu (
www.public-health.uiowa.edu/faculty-staff/faculty/directory/faculty-detail.asp?emailAddress=dawei-liu@uiowa.edu)
as a scientific advisor. Dr. Liu's guidance and expertise will help advance
the Company's commitment to a research-focused strategy for developing and
introducing innovative new products.
…. Original article : OrthoAccel Technologies, Inc. Announces New Scientific Advisor.
Largest U.S. Surrogacy Agency Appoints Director of Client Development, Europe
LOS ANGELES, February 23, 2011 – Since 1996, Growing Generations has been a company passionately dedicated
to the vision of creating life and in the process, changing the world. The
company's mission is simple-to make it safer, easier, and more enjoyable for
individuals and couples, surrogates, egg and sperm donors, and other
professionals, to grow families through assisted … Read more >>.
The King’s Speech Rolls Out the Red Carpet for Stuttering
Media Availability
MEMPHIS, Tennessee, February 24, 2011 – The following was released today by The Stuttering Foundation:
WHAT: Jane Fraser, President, The Stuttering Foundation
(www.stutteringhelp.org) is available for immediate telephone
interview regarding The King's Speech and its overwhelmingly positive impact
on the stuttering community.
– People who stutter have shared their own, … Read the original article on Gaea Times at : The King's Speech Rolls Out the Red Carpet for Stuttering.
Health on the Agenda at Food ingredients Asia-China Trade Show
SHANGHAI, February 25, 2011 – The annual meeting of the Chinese food industry is approaching; Fi
Asia-China, Hi Ni China will be held on 21-23 June, heavily focusing on the
growing health market in China, and offering thousands of buyers and sellers
a place to meet, network and discuss business developments in the country and
beyond.
… Read more : Health on the Agenda at Food ingredients Asia-China Trade Show.
Stuttering Reigns King at the Oscars
MEMPHIS, Tennessee, February 28, 2011 – Jane Fraser, president, The Stuttering Foundation (www.stutteringhelp.org),
issued the following reaction to the Oscar awards:
"It is an eloquently golden night for people who stutter. The King's
Speech has been a godsend for the entire stuttering community.
"Tom Hooper gave us an inspirational hero, …. Source : Stuttering Reigns King at the Oscars.
Kuros Treats First Patient With KUR-023, its Novel Dural Sealant Product Candidate
European Study is First Clinical Assessment of Kuros' Proprietary Synthetic Technology
ZURICH, February 28, 2011 – Kuros Biosurgery AG, a biotechnology company focused on the
development of novel biomaterials and bioactive-biomaterial combination
products for trauma, wound and spinal indications, announced today that it
has treated the first patient in a pilot clinical trial investigating the
safety and efficacy of … Read : Kuros Treats First Patient With KUR-023, its Novel Dural Sealant Product Candidate.
Medunik Canada: A Team Strongly Committed to Bringing Novel Orphan Drugs to Canadians With Rare Diseases
A Strategic Turnkey Partnership Opportunity for International Pharmaceuticals
BLAINVILLE, Quebec, February 28, 2011 – ??ric Gervais, Executive Vice-President of Medunik Canada (
medunikcanada.ca/en), is proud to announce the Management Team
(medunikcanada.ca/en/management) of this recently created company.
Medunik Canada is a Quebec pharmaceutical company with 60 employees and one
unique mission – bring novel orphan drugs to Canadians with rare …. Source : Medunik Canada: A Team Strongly Committed to Bringing Novel Orphan Drugs to Canadians With Rare Diseases.
EXPAT Kiwis Can Support St John Online With Christchurch Earthquake Work
WELLINGTON, New Zealand, February 28, 2011 – Kiwis worldwide can go online to support St John, the ambulance service
provider helping residents and communities in Christchurch after the recent
earthquake which devastated much of the city.
The website www.donatechristchurch.co.nz enables internet and
mobile phone users abroad to make a donation to St John and …. Original article : EXPAT Kiwis Can Support St John Online With Christchurch Earthquake Work.